Snoeys J - Search Results

1

From preclinical to human--prediction of oral absorption and drug-drug interaction potential using physiologically based pharmacokinetic (PBPK) modeling approach in an industrial setting: a workflow by using case example.

Sinha VK, Snoeys J, Osselaer NV, Peer AV, Mackie C, Heald D. Sinha VK, et al. Among authors: snoeys j. Biopharm Drug Dispos. 2012 Mar;33(2):111-21. doi: 10.1002/bdd.1782. Biopharm Drug Dispos. 2012. PMID: 22383166

2

The successes and failures of physiologically based pharmacokinetic modeling: there is room for improvement.

Poggesi I, Snoeys J, Van Peer A. Poggesi I, et al. Among authors: snoeys j. Expert Opin Drug Metab Toxicol. 2014 May;10(5):631-5. doi: 10.1517/17425255.2014.888058. Epub 2014 Feb 11. Expert Opin Drug Metab Toxicol. 2014. PMID: 24517185

3

Physiologically based pharmacokinetic modeling in drug discovery and development: a pharmaceutical industry perspective.

Jones HM, Chen Y, Gibson C, Heimbach T, Parrott N, Peters SA, Snoeys J, Upreti VV, Zheng M, Hall SD. Jones HM, et al. Among authors: snoeys j. Clin Pharmacol Ther. 2015 Mar;97(3):247-62. doi: 10.1002/cpt.37. Epub 2015 Jan 9. Clin Pharmacol Ther. 2015. PMID: 25670209 Review.

4

A physiologically based pharmacokinetic modeling approach to predict drug-drug interactions between domperidone and inhibitors of CYP3A4.

Templeton I, Ravenstijn P, Sensenhauser C, Snoeys J. Templeton I, et al. Among authors: snoeys j. Biopharm Drug Dispos. 2016 Jan;37(1):15-27. doi: 10.1002/bdd.1992. Biopharm Drug Dispos. 2016. PMID: 26356245 Clinical Trial.

5

Ibrutinib Dosing Strategies Based on Interaction Potential of CYP3A4 Perpetrators Using Physiologically Based Pharmacokinetic Modeling.

de Zwart L, Snoeys J, De Jong J, Sukbuntherng J, Mannaert E, Monshouwer M. de Zwart L, et al. Among authors: snoeys j. Clin Pharmacol Ther. 2016 Nov;100(5):548-557. doi: 10.1002/cpt.419. Epub 2016 Aug 27. Clin Pharmacol Ther. 2016. PMID: 27367453 Clinical Trial.

6

In vitro and physiologically-based pharmacokinetic based assessment of drug-drug interaction potential of canagliflozin.

Mamidi RNVS, Dallas S, Sensenhauser C, Lim HK, Scheers E, Verboven P, Cuyckens F, Leclercq L, Evans DC, Kelley MF, Johnson MD, Snoeys J. Mamidi RNVS, et al. Among authors: snoeys j. Br J Clin Pharmacol. 2017 May;83(5):1082-1096. doi: 10.1111/bcp.13186. Epub 2016 Dec 20. Br J Clin Pharmacol. 2017. PMID: 27862160 Free PMC article.

7

Advancing Predictions of Tissue and Intracellular Drug Concentrations Using In Vitro, Imaging and Physiologically Based Pharmacokinetic Modeling Approaches.

Guo Y, Chu X, Parrott NJ, Brouwer KLR, Hsu V, Nagar S, Matsson P, Sharma P, Snoeys J, Sugiyama Y, Tatosian D, Unadkat JD, Huang SM, Galetin A; International Transporter Consortium. Guo Y, et al. Among authors: snoeys j. Clin Pharmacol Ther. 2018 Nov;104(5):865-889. doi: 10.1002/cpt.1183. Epub 2018 Sep 12. Clin Pharmacol Ther. 2018. PMID: 30059145 Free PMC article.

8

Pharmacokinetic Drug-Drug Interaction of Apalutamide, Part 2: Investigating Interaction Potential Using a Physiologically Based Pharmacokinetic Model.

Van den Bergh A, Snoeys J, De Zwart L, Ward P, Lopez-Gitlitz A, Ouellet D, Monshouwer M, Chien C. Van den Bergh A, et al. Among authors: snoeys j. Clin Pharmacokinet. 2020 Sep;59(9):1149-1160. doi: 10.1007/s40262-020-00881-3. Clin Pharmacokinet. 2020. PMID: 32338346

9

Physiologically-Based Pharmacokinetic Modeling in Renal and Hepatic Impairment Populations: A Pharmaceutical Industry Perspective.

Heimbach T, Chen Y, Chen J, Dixit V, Parrott N, Peters SA, Poggesi I, Sharma P, Snoeys J, Shebley M, Tai G, Tse S, Upreti VV, Wang YH, Tsai A, Xia B, Zheng M, Zhu AZX, Hall S. Heimbach T, et al. Among authors: snoeys j. Clin Pharmacol Ther. 2021 Aug;110(2):297-310. doi: 10.1002/cpt.2125. Epub 2020 Dec 30. Clin Pharmacol Ther. 2021. PMID: 33270249 Free PMC article.

10

Prediction of Drug-Drug Interactions After Esketamine Intranasal Administration Using a Physiologically Based Pharmacokinetic Model.

Willemin ME, Zannikos P, Mannens G, de Zwart L, Snoeys J. Willemin ME, et al. Among authors: snoeys j. Clin Pharmacokinet. 2022 Aug;61(8):1115-1128. doi: 10.1007/s40262-022-01123-4. Epub 2022 May 17. Clin Pharmacokinet. 2022. PMID: 35579824

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

93 results

Search Page